Mus musculus
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA165135 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:The first genetic hits towards leukemia are thought often to confer to the mutant clone a slight proliferative/survial advantage. These pre-malignant clones can then be maintained under physiological cues in normal pool for long periods. We have searched for this type of first genetic hits and found that ectopic expression of novel nucleoporin 98 (NUP98)-homeodomain fusion proteins in primitive bone marrow cells can induce long-lasting hematopoietic stem cell (HSC) activity in these cells. More specifically, NUP98-CDX1/2 was able to sustain HSC activity with high frequencies despite massive in vitro expansions and in vivo residence. Continual expression of NUP98-CDX1/2 did not perturb lymphoid, myeloid or erythroid/platelet differentiation and NUP98-CDX1/2 was able to reprogram committed progenitors into cells with attributes of HSC. Switching off of NUP98-CDX1/2 expression did not lead to “return” to normal HSC but acute differentiation. Related NUP98-CDX4 induced leukemia with the shortest latency ever reported for HOX transcription factors. In this case switching off of NUP98-CDX4 expression cured the full-blown leukemia and again the cured cells showed only transient repopulating activity in vivo. These two types of pre-leukemic cells generated here will provide useful models for elucidating the self-renewal mechanisms of HSC as well as leukemic stem cells. Total RNA from NUP98-CDX lines was compared to EGFP overexpressing lines. The experiment was done in triplicate.
2012-12-01 | E-GEOD-37900 | biostudies-arrayexpress
Project description:Transcription profiling by array of human bone marrow mesenchymal stem cells overexpressing Dlk1
2025-01-22 | E-MEXP-560 | ExpressionAtlas
Project description:The first genetic hits towards leukemia are thought often to confer to the mutant clone a slight proliferative/survial advantage. These pre-malignant clones can then be maintained under physiological cues in normal pool for long periods. We have searched for this type of first genetic hits and found that ectopic expression of novel nucleoporin 98 (NUP98)-homeodomain fusion proteins in primitive bone marrow cells can induce long-lasting hematopoietic stem cell (HSC) activity in these cells. More specifically, NUP98-CDX1/2 was able to sustain HSC activity with high frequencies despite massive in vitro expansions and in vivo residence. Continual expression of NUP98-CDX1/2 did not perturb lymphoid, myeloid or erythroid/platelet differentiation and NUP98-CDX1/2 was able to reprogram committed progenitors into cells with attributes of HSC. Switching off of NUP98-CDX1/2 expression did not lead to “return” to normal HSC but acute differentiation. Related NUP98-CDX4 induced leukemia with the shortest latency ever reported for HOX transcription factors. In this case switching off of NUP98-CDX4 expression cured the full-blown leukemia and again the cured cells showed only transient repopulating activity in vivo. These two types of pre-leukemic cells generated here will provide useful models for elucidating the self-renewal mechanisms of HSC as well as leukemic stem cells.
2012-12-01 | GSE37900 | GEO
Project description:Transcription profiling by array of mouse whole bone marrow after c-Jun induction
2016-11-09 | E-GEOD-84838 | ExpressionAtlas
Project description:Transcription profiling by array of mouse bone marrow derived eosinophils mutant for miR-223
2015-10-22 | E-MEXP-3350 | ExpressionAtlas
Project description:Murine bone marrow gene expression profiling
2015-08-06 | E-GEOD-42257 | ExpressionAtlas
Project description:Transcription profiling by array of mouse bone marrow macrophages mutant for ATF3 after treatment with lipopolysaccharide
2014-07-03 | E-TABM-102 | ExpressionAtlas
Project description:Transcription profiling by array of mouse bone marrow cells transfected with miR 142-3p mimic oligo
2015-11-05 | E-GEOD-39803 | ExpressionAtlas
Project description:Transcription profiling by array of mouse bone marrow derived macrophages mutant for NAT5 after treatment with lipopolysaccharide
2014-07-30 | E-GEOD-26343 | ExpressionAtlas
Project description:Transcription profiling by array of mouse bone marrow-derived macrophages treated with recombinant growth differentiation factor 11 (rGDF11)
2016-10-20 | E-GEOD-84609 | ExpressionAtlas